European Best Practice Guidelines 9-13 -: Anaemia management

被引：45

作者：

Jacobs, C

Hörl, WH

Macdougall, IC

Valderrábano, F

Parrondo, I

Abraham, IL

Segner, A

机构：

来源：

NEPHROLOGY DIALYSIS TRANSPLANTATION | 2000年 / 15卷

关键词：

D O I：

10.1093/ndt/15.suppl_4.33

中图分类号：

R3 [基础医学]; R4 [临床医学];

学科分类号：

1001 ; 1002 ; 100602 ;

摘要：

引用

页码：33 / 42

页数：10

共 14 条

[1] Secular trends in recombinant erythropoietin therapy among the US hemodialysis population: 1990-1996 [J].

Cotter, DJ ;

Thamer, M ;

Kimmel, PL ;

Sadler, JH .

KIDNEY INTERNATIONAL, 1998, 54 (06) :2129-2139

[2] The haematopoietic effect of recombinant human erythropoietin in haemodialysis is independent of the mode of administration (iv or sc) [J].

De Schoenmakere, G ;

Lameire, N ;

Dhondt, A ;

Van Loo, A ;

Van der Goten, J ;

Duym, P ;

Vanholder, R .

NEPHROLOGY DIALYSIS TRANSPLANTATION, 1998, 13 (07) :1770-1775

[3]

European Dialysis and Transplant Association, 1999, NEPHROL DIAL TRAN S5, V14, P19

[4] Anemia management of adult hemodialysis patients in the US: Results from the 1997 ESRD Core Indicators Project [J].

Frankenfield, D ;

Johnson, CA ;

Wish, JB ;

Rocco, MV ;

Madore, F ;

Owen, WF .

KIDNEY INTERNATIONAL, 2000, 57 (02) :578-589

[5]

Johnson CA, 1999, PERITON DIALYSIS INT, V19, P578

[6] Subcutaneous compared with intravenous epoetin in patients receiving hemodialysis [J].

Kaufman, JS ;

Reda, DJ ;

Fye, CL ;

Goldfarb, DS ;

Henderson, WG ;

Kleinman, JG ;

Vaamonde, CA .

NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (09) :578-583

[7] Efficiency of once-weekly subcutaneous administration of recombinant human erythropoietin versus th ree times a week administration in hemodialysis patients [J].

Lago, M ;

PerezGarcia, R ;

deVinuesa, MSG ;

Anaya, F ;

Valderrabano, F .

NEPHRON, 1996, 72 (04) :723-724

[8] ONCE WEEKLY VERSUS TWICE WEEKLY SUBCUTANEOUS ADMINISTRATION OF RECOMBINANT-HUMAN-ERYTHROPOIETIN IN HEMODIALYSIS-PATIENTS [J].

LUI, SF ;

WONG, KC ;

LI, PKT ;

LAI, KN .

AMERICAN JOURNAL OF NEPHROLOGY, 1992, 12 (1-2) :55-60

[9]

*NKF DOQI GUID, 1997, AM J KIDNEY DIS S3, V30, pS213

[10] INTRAVENOUS VERSUS SUBCUTANEOUS DOSING OF EPOETIN ALFA IN HEMODIALYSIS-PATIENTS [J].

PAGANINI, EP ;

ESCHBACH, JW ;

LAZARUS, JM ;

VANSTONE, JC ;

GIMENEZ, LF ;

GRABER, SE ;

EGRIE, JC ;

OKAMOTO, DM ;

GOODKIN, DA .

AMERICAN JOURNAL OF KIDNEY DISEASES, 1995, 26 (02) :331-340

← 1 2 →